Ketamine is getting attention for how fast it can work, sometimes within hours. A new review in Neuropsychiatric Disease and Treatment looks at what the research supports for people in a suicidal crisis. IV ketamine may ease suicidal thoughts in the short term for some adults. The authors stress that it works best as one part of ongoing care, including safety planning and follow-up support.
Source: Słupska A, et al. “Ketamine and Esketamine in Acute Suicidal Presentations: Evidence, Limits, and a Conceptual Recovery-Enabling Downstaging Framework.” Neuropsychiatric Disease and Treatment, 2026;22:641718. doi.org/10.2147/NDT.S641718
New research presented at the ANESTHESIOLOGY 2026 annual meeting looked at six clinical trials with more than 1,800 women. Those who received ketamine or esketamine during or after surgery had fewer depressive symptoms in the first two weeks after delivery. Researchers say larger studies are still needed.
Sources: EurekAlert! / American Society of Anesthesiologists, Oct. 17, 2026
May is Mental Health Awareness Month — a time to open up conversations we often keep quiet. If you or someone you love has been struggling with depression, anxiety, or PTSD, you already know how hard that silence can feel. You may have tried medications, therapy, or both, and still found yourself searching for something that actually works.
Ketamine therapy for mental health is giving new hope to people who haven’t found relief through traditional treatments. At Charleston Ketamine Center, we believe everyone deserves to understand their options — so let’s talk about what ketamine treatment is, who it may help, and what the experience actually looks like.
What Is Mental Health Awareness Month?
Every May, Mental Health Awareness Month encourages people across the country to break the stigma around mental health conditions, seek support, and share their stories. According to the National Alliance on Mental Illness (NAMI), 1 in 5 adults in the U.S. experiences a mental health condition each year — yet many people go without treatment.
Awareness month is a reminder that mental health conditions like depression, anxiety, and post-traumatic stress disorder (PTSD) are medical conditions — not personal failures. And like any medical condition, they deserve evidence-based treatment options.
What Is Ketamine Therapy?
Ketamine is a medication that has been used safely in medical settings for decades, primarily as an anesthetic. In recent years, researchers and clinicians have found that low-dose ketamine infusions may significantly reduce symptoms of certain mental health conditions — sometimes within hours or days, rather than the weeks it typically takes for traditional antidepressants to take effect.
Ketamine works differently from most mental health medications. Rather than targeting serotonin or dopamine (as most antidepressants do), ketamine acts on a receptor in the brain called NMDA (N-methyl-D-aspartate). This process may help restore connections between brain cells that have been weakened by long-term stress and depression.
At Charleston Ketamine Center, ketamine is administered by a medical doctor in a safe, monitored clinical setting — never at home, and never without oversight.
Who Might Benefit From Ketamine Therapy for Mental Health?
Ketamine therapy may be an option for people living with:
Research suggests ketamine may be particularly helpful for people who have tried other treatments without success. If you’ve felt like you’ve run out of options, it may be worth having a conversation with a provider about whether ketamine is appropriate for you.
When to Talk to a Provider
If any of these sound familiar, it may be worth reaching out for a consultation:
You don’t need to have everything figured out before making a call. A consultation is simply a chance to ask questions and learn more.
Taking the Next Step This Mental Health Awareness Month
Mental Health Awareness Month is about more than raising awareness — it’s about taking action. If you or someone you care about has been struggling, this May is a meaningful time to explore what options might help.
Ketamine therapy for mental health is not a last resort — it’s a legitimate, medically supervised treatment that may offer relief when other approaches haven’t. At Charleston Ketamine Center, our physician is here to have an honest conversation about whether it’s right for you.
Call us at (843) 480-2273 to take the next step — at whatever pace feels right for you.
This article is for educational purposes only and does not constitute medical advice. Please consult a qualified healthcare provider to discuss your individual situation.
This article examines the evolving understanding of depression and the mechanisms behind ketamine’s antidepressant effects. It discusses the shift away from the traditional “chemical imbalance” theory toward a broader focus on neural connectivity, synaptic function, and brain plasticity. The authors explain how ketamine may rapidly restore communication pathways within the brain, offering a different therapeutic approach than conventional antidepressants. The paper also explores emerging research into multiscale plasticity and how these findings may influence the future of depression treatment and neuroscience.
A recent study published on PubMed highlights promising findings in the treatment of depression using intranasal ketamine. Researchers found that racemic ketamine is non-inferior to esketamine, meaning it delivers comparable improvements in depressive symptoms while potentially offering a more cost-effective and accessible option for patients. This is especially important as demand grows for fast-acting alternatives to traditional antidepressants.
At Charleston Ketamine Center, these findings reinforce the value of ketamine-based therapies in real-world clinical care. Intranasal treatment options provide a convenient, minimally invasive approach while maintaining strong therapeutic outcomes. As research continues to evolve, ketamine therapy remains a powerful tool in helping patients achieve meaningful relief from depression and improve overall quality of life.
Telehealth ketamine therapy provider Mindbloom is facing a wrongful-death lawsuit after a 27-year-old male patient died from ketamine toxicity in October 2023, allegedly while under Mindbloom’s at-home treatment program. The lawsuit contends that the company failed to properly screen the patient—who had a documented history of substance-use disorder and hypertension—and did not follow through with required follow-up monitoring once he missed mandated check-ins. The patient’s family argues that, despite Mindbloom’s public claim that none of its ~60,000 patients had ever overdosed, this case marks a tragic exception. Mindbloom, while expressing sympathy for the death, denies negligence and asserts its care protocols are supported by peer-reviewed research and numerous prior treatments.